Magnesium Replacement Calculator
Calculate magnesium replacement dose from serum level and weight for hypomagnesemia. Enter values for instant results with step-by-step formulas.
Formula
Severity-based dosing: Severe (<1.0): 4-8g MgSO4 IV; Moderate (1.0-1.5): 2-4g IV; Mild (1.5-1.8): 1-2g IV or oral
Magnesium replacement dosing is based on severity of hypomagnesemia rather than a precise deficit formula because only 1% of total body magnesium is extracellular. 1 g MgSO4 = 8.12 mEq = 4.06 mmol elemental Mg. Approximately 50% of IV magnesium is renally excreted within 24 hours, so repeated dosing over days is needed for full repletion.
Worked Examples
Example 1: Moderate Hypomagnesemia in Post-Surgical Patient
Problem: A 75 kg patient post-colectomy has a serum Mg of 1.3 mg/dL with normal renal function. Target Mg 2.0 mg/dL. The patient is tolerating oral intake but has mild muscle cramps.
Solution: Current Mg: 1.3 mg/dL (moderate hypomagnesemia)\nTarget: 2.0 mg/dL\nIV dose: 2 g MgSO4 (16.2 mEq, 8.1 mmol)\nDilute in 200 mL NS, infuse over 2 hours\nFollow with oral Mg oxide 400 mg twice daily\nRecheck serum Mg in 12 hours\nAlso check K+ and Ca2+ levels
Result: IV: 2 g MgSO4 over 2 hours | Oral: MgOxide 400 mg BID | Recheck in 12 hours
Example 2: Severe Hypomagnesemia with Torsades de Pointes
Problem: A 65 kg patient on furosemide presents with Mg 0.8 mg/dL and torsades de pointes on telemetry. Normal renal function.
Solution: Current Mg: 0.8 mg/dL (SEVERE hypomagnesemia)\nMEDICAL EMERGENCY - torsades de pointes present\nImmediate: 2 g MgSO4 IV push over 2-5 minutes\nFollowed by: 4-6 g MgSO4 IV over 12-24 hours\nContinuous cardiac monitoring mandatory\nRepeat dosing daily for 2-5 days to replete stores\nCheck and replace K+ and Ca2+ concurrently
Result: STAT: 2 g MgSO4 IV push | Then 6 g over 24 hrs | Continuous monitoring | Multi-day repletion
Frequently Asked Questions
How is the IV magnesium dose calculated?
IV magnesium dosing is primarily based on the severity of hypomagnesemia rather than on a precise deficit calculation because the relationship between serum levels and total body stores is unreliable. For severe hypomagnesemia below 1.0 mg/dL, the typical dose is 4 to 8 grams of magnesium sulfate (MgSO4) administered IV over 12 to 24 hours. For moderate hypomagnesemia of 1.0 to 1.5 mg/dL, 2 to 4 grams IV is typical. For mild hypomagnesemia of 1.5 to 1.8 mg/dL, 1 to 2 grams IV or oral replacement may suffice. One gram of MgSO4 contains approximately 8.12 mEq (4.06 mmol) of elemental magnesium. Because approximately half of administered IV magnesium is excreted by the kidneys within 24 hours, repeated dosing over 2 to 5 days is often needed to fully replete total body stores, especially in severe deficiency.
What is the maximum safe IV magnesium infusion rate?
The maximum safe IV magnesium infusion rate depends on the clinical urgency and the patient clinical status. For routine replacement in non-emergency situations, the standard maximum rate is 1 gram of MgSO4 per hour, diluted in 100 mL of normal saline or D5W and infused slowly to avoid adverse effects. For life-threatening situations such as torsades de pointes or eclamptic seizures, 2 grams can be given as an IV push over 2 to 5 minutes. Rapid infusion carries risks including hypotension due to magnesium vasodilatory effects, facial flushing, warmth, bradycardia, and potentially dangerous hypermagnesemia. During infusion, patients should be monitored for signs of magnesium toxicity including loss of deep tendon reflexes (earliest sign at serum Mg of 7 to 10 mg/dL), respiratory depression, and cardiac conduction abnormalities. Calcium gluconate should be available at the bedside as a reversal agent.
What oral magnesium formulations are available?
Several oral magnesium formulations are available, each with different bioavailability and side effect profiles. Magnesium oxide contains the highest percentage of elemental magnesium (60 percent) but has poor bioavailability of only 4 to 5 percent and commonly causes diarrhea and gastrointestinal upset. Magnesium citrate has moderate bioavailability (approximately 25 to 30 percent) and is better absorbed but is also used as an osmotic laxative. Magnesium glycinate (chelated) has good bioavailability and is better tolerated with fewer GI side effects, making it preferred for chronic supplementation. Magnesium chloride has reasonable bioavailability of approximately 20 percent. Magnesium lactate and gluconate are also well absorbed. For acute oral replacement in hospitalized patients, magnesium oxide 400 to 800 mg (240 to 480 mg elemental magnesium) divided into two to three daily doses is commonly prescribed. The primary limitation of oral replacement is diarrhea, which paradoxically can worsen magnesium losses.
How should magnesium be monitored during replacement?
Monitoring during magnesium replacement therapy involves both laboratory and clinical assessments. Serum magnesium levels should be checked every 6 to 12 hours during active IV replacement and daily during oral supplementation until levels stabilize in the normal range. Because serum levels can appear normal while total body stores remain depleted, replacement should typically continue for several days beyond normalization of serum levels. Deep tendon reflexes should be checked regularly during IV infusion, particularly at higher rates, as loss of reflexes is the first clinical sign of hypermagnesemia. Blood pressure and heart rate monitoring is important because magnesium causes vasodilation and can potentiate hypotension. Renal function should be assessed because magnesium is primarily excreted by the kidneys and can accumulate to dangerous levels in renal insufficiency. Concurrent potassium and calcium levels should be monitored since these electrolytes are commonly deranged alongside magnesium.
How does renal function affect magnesium replacement?
Renal function is the primary determinant of magnesium homeostasis because the kidneys are responsible for excreting approximately 90 to 95 percent of the filtered magnesium load under normal conditions. In patients with renal insufficiency, impaired magnesium excretion means that standard replacement doses can rapidly produce dangerous hypermagnesemia, which can cause respiratory failure, cardiac arrest, and death. For patients with mild to moderate renal impairment (GFR 30 to 60 mL/min), magnesium replacement doses should be reduced by approximately 50 percent with more frequent monitoring of serum levels every 4 to 6 hours. For patients with severe renal impairment (GFR below 30 mL/min), IV magnesium should be used very cautiously at 25 percent of standard doses or avoided entirely unless the hypomagnesemia is severe and symptomatic. Dialysis patients represent a unique situation where magnesium levels are influenced by the dialysate magnesium concentration, and replacement should be coordinated with the nephrology team.
What is the relationship between magnesium and cardiac arrhythmias?
Magnesium plays a critical role in cardiac electrophysiology and its deficiency is strongly associated with several dangerous arrhythmias. The most important association is with torsades de pointes (TdP), a polymorphic ventricular tachycardia that occurs in the setting of prolonged QT interval. Magnesium is the first-line treatment for TdP regardless of the serum magnesium level because it stabilizes cardiac membrane potential and suppresses early afterdepolarizations that trigger the arrhythmia. Hypomagnesemia also increases the risk of atrial fibrillation, particularly in post-cardiac surgery patients where prophylactic magnesium supplementation has been shown to reduce AF incidence. Digoxin toxicity is potentiated by hypomagnesemia because both magnesium and digoxin compete for binding sites on the Na-K-ATPase pump. Additionally, hypomagnesemia causes refractory ventricular arrhythmias in acute myocardial infarction. Current guidelines recommend maintaining serum magnesium above 2.0 mg/dL in patients with acute coronary syndromes and cardiac arrhythmias.